Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | UTRN | P46939 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | PI4KA | P42356 | 1/20 | 0.31 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 4/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | DHODH | Q02127 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20370689 | 0.93 | MAPT (0.33) | MAPTHDAC1PIK3CAPI4KAPI4KB | |
| SCHEMBL20370693 | 0.91 | MAPT (0.36) | MAPTLMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL20370670 | 0.86 | PIK3CA (0.40) | LMNAPIK3CAPI4KAPI4KBMEN1 | |
| SCHEMBL20370688 | 0.83 | TOP1 (0.32) | MAPTNPSR1 | |
| SCHEMBL20370728 | 0.83 | PIK3CA (0.38) | LMNAPIK3CAPI4KAPI4KBMEN1 | |
| SCHEMBL16167032 | 0.83 | LMNA (0.40) | MAPTLMNAMEN1KMT2ANPSR1 | |
| SCHEMBL20370721 | 0.82 | PIK3CA (0.38) | HDAC1PIK3CAPI4KAPI4KBKMT2A | |
| SCHEMBL20370736 | 0.82 | MAPT (0.38) | MAPTMEN1KMT2AALDH1A1POLB | |
| SCHEMBL20370680 | 0.81 | MEN1 (0.40) | MAPTLMNAPIK3CAPI4KAPI4KB | |
| SCHEMBL20370704 | 0.81 | MAPT (0.33) | MAPTALDH1A1NPSR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10854823-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-12-01 | — | — | US | disclosed |
| US-20180198074-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-07-12 | — | — | US | disclosed |
| US-20180198074-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10854823-B2 | Heterocyclic compound and organic light-emitting device including the same | CRY1, CRY2, CYP1A1 | MAPT 1408/4885LMNA 3190/4885UTRN 3531/4885 |
| US-20180198074-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CYP1A1 | MAPT 1408/4885LMNA 3190/4885UTRN 3531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.